Welcome to our dedicated page for TD SYNNEX SEC filings (Ticker: SNX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on TD SYNNEX's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into TD SYNNEX's regulatory disclosures and financial reporting.
A shareholder of SNX has filed a Rule 144 notice to sell 20,000 shares of common stock on the NYSE through Morgan Stanley Smith Barney LLC. The planned sale, dated around 01/12/2026, has an indicated aggregate market value of $2,999,579.43, compared with 81,437,855 shares of common stock outstanding. The shares to be sold were acquired on 01/12/2026 via a stock option exercise from the issuer for cash.
Over the past three months, the POLK FAMILY TRUST U/T/A DTD 04/25/2007 has reported additional sales of SNX common stock: 3,000 shares on 11/04/2025 for $451,698.18, 3,000 shares on 12/04/2025 for $465,086.50, and 2,853 shares on 01/05/2026 for $438,754.28. The signer represents that they are not aware of undisclosed material adverse information about the issuer.
TD SYNNEX Corporation reported that it has released its financial results for the fiscal fourth quarter ended November 30, 2025. The company also announced a cash dividend of $0.48 per common share to be paid in the first quarter of its 2026 fiscal year. The details of the quarter’s performance and the dividend timing are provided in an accompanying press release.
The company furnished this information via a press release attached as an exhibit, rather than including full financial statements in this report.
TD SYNNEX CORP director reports planned stock sales on Form 4. On 01/05/2026, the reporting person, a director of TD SYNNEX, sold a total of 5,000 shares of common stock in multiple transactions. The sales were coded as open-market sales and were made under a Rule 10b5-1 trading plan that was adopted on July 14, 2025.
The shares were sold at weighted average prices ranging from about $152.81 to $156.42 across several price intervals, as detailed in the footnotes. After these transactions, the director reported owning 47,515 shares of TD SYNNEX common stock directly.
TD SYNNEX Corp insider reports planned stock sales by family trust. A director and Hyve Solutions executive of TD SYNNEX Corp filed a Form 4 disclosing multiple open-market sales of common stock on January 5, 2026. The trades were executed under a pre-arranged Rule 10b5-1 trading plan adopted on October 13, 2024 on behalf of the Polk family trust, where the insider is a trustee. The reported sales were made at weighted average prices in ranges such as $152.43–$152.94, $153.05–$153.96, $154.06–$154.80, and $155.19–$155.86, plus one sale at $156.79. Following these transactions, the trust held 72,807 shares indirectly, and the insider also held 34,099 shares directly.
TD SYNNEX Corp reported an insider transaction by a director involving a small sale of common stock. On 12/04/2025, the director sold 168 shares of TD SYNNEX common stock at a price of $153.38 per share, coded as an open-market sale. After this transaction, the director beneficially owns 7,162 shares, held directly. The filing notes that these sales were carried out under a Rule 10b5-1 trading plan adopted on August 2, 2025, which is a pre-arranged plan designed to allow insiders to trade shares according to preset instructions.
TD SYNNEX reported insider stock sales by a director and Hyve Solutions executive. On 12/04/2025, a total of 3,000 shares of common stock were sold in several transactions by a family trust, all coded as open-market sales. The shares were sold at weighted average prices of $154.47, $155.72, and $156.01, with underlying trade prices ranging from $154.17 to $155.91.
The filing notes these transactions were made under a Rule 10b5-1 trading plan adopted on October 13, 2024 for the Polk family trust, of which the insider is a trustee. After these sales, the trust indirectly holds 75,660 shares, and the insider directly holds an additional 34,099 shares of TD SYNNEX common stock.
TD SYNNEX (SNX) has a notice of proposed insider sale under Rule 144 for 5,853 shares of common stock to be sold through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $901,420.53. These shares were acquired as restricted stock units from the issuer on 01/24/2023, with the same date listed as the payment date.
The filing also lists recent sales of TD SYNNEX common stock over the past three months for the same account group: 3,000 shares sold on 11/04/2025 for gross proceeds of $451,697.45, 17,500 shares sold on 10/09/2025 for $2,738,783.60, and 3,000 shares sold on 10/06/2025 for $477,258.30. The issuer reports 81,437,855 shares of common stock outstanding.
TD SYNNEX Corp director reports planned stock sales under Rule 10b5-1 plan. A board member of TD SYNNEX Corp (ticker SNX) filed details of two open-market sales of common stock dated 12/01/2025. The reporting person sold 2,438 shares at a weighted average price of $151.72 and 2,562 shares at a weighted average price of $152.48, both marked as disposition transactions.
The transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on July 14, 2025, which is designed to allow pre-arranged trading while addressing insider trading concerns. After these sales, the director beneficially owns 52,515 shares of TD SYNNEX common stock directly. The filing notes that the price figures represent weighted averages across multiple trades within stated price ranges and that full price breakdowns are available upon request.
TD SYNNEX (SNX) director and Hyve Solutions executive reported open‑market sales totaling 3,000 shares on 11/04/2025 under a Rule 10b5-1 trading plan adopted on October 13, 2024. The trust sold 600 shares at a weighted average price of $149.81 (range $149.50–$149.99), 1,761 shares at $150.59 (range $150.05–$150.99), and 639 shares at $151.21 (range $151.07–$151.36).
Following the transactions, beneficial ownership stood at 78,660 shares held indirectly by a trust and 34,099 shares held directly.
TD SYNNEX (SNX): FMR LLC filed an amended Schedule 13G reporting a passive beneficial ownership of 6,482,929.92 shares of TD SYNNEX common stock, representing 7.9% of the class as of 09/30/2025. FMR reports sole voting power over 6,454,541.96 shares and sole dispositive power over 6,482,929.92 shares, with no shared voting or dispositive power.
Abigail P. Johnson is also a reporting person, listing sole dispositive power over 6,482,929.92 shares and no voting power. The filing states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. It notes that one or more other persons may have rights to receive dividends or sale proceeds, with no single such interest exceeding five percent of the total outstanding common stock.